Pharmacists’ perception about providing services to patients with headaches in primary care

  • Ana Homšek University in Belgrade – Faculty of Pharmacy, Department of Pharmacokinetics and Clinical Pharmacy
  • Marija Jovanović University in Belgrade – Faculty of Pharmacy, Department of Pharmacokinetics and Clinical Pharmacy
  • Maša Roganović University in Belgrade – Faculty of Pharmacy, Department of Pharmacokinetics and Clinical Pharmacy
  • Milena Kovačević University in Belgrade – Faculty of Pharmacy, Department of Pharmacokinetics and Clinical Pharmacy
  • Milica Ćulafić University in Belgrade – Faculty of Pharmacy, Department of Pharmacokinetics and Clinical Pharmacy
  • Sandra Vezmar Kovačević University in Belgrade – Faculty of Pharmacy, Department of Pharmacokinetics and Clinical Pharmacy
  • Katarina Vučićević University in Belgrade – Faculty of Pharmacy, Department of Pharmacokinetics and Clinical Pharmacy
  • Branislava Miljković University in Belgrade – Faculty of Pharmacy, Department of Pharmacokinetics and Clinical Pharmacy

Abstract


 

Since headaches represent one of the most common disabling conditions in the world1 and can be treated with over-the-counter drugs, the role of pharmacists in caring for these patients has been recognized as very important. The research aim was to review primary health care pharmacists’ perception regarding patient service they provide and the conducted education devoted to headaches. Data were collected through a survey adapted from the published article2 and analysed in SPSS and Microsoft Excel. The survey was completed by 43 primary health care pharmacists (90.7% women, age 27-64). The survey reliability was verified using the Cronbach’s test (αB = 0.727; αC = 0.880). Most of the surveyed pharmacists believe that they listen carefully to patients with headaches (65% always, 27.9% often), 44.7% always check interactions, while 86.04% always advise the patient on proper drug administration. However, 34.88% report that they never contact doctors if the drug is expensive, not reimbursable or causes an adverse reaction that limits its use, and 32.55% only sometimes do so. Most pharmacists believe education was useful to better understand patients and counsel them about headaches (97.67-100%), while a slightly smaller percentage (93.02%) thinks it helped them learn to identify a migraine patient and refer him to a doctor. The perception of most pharmacists is that they advise patients on headache treatment even without prior education, but after it, the service would be more complete. The study results indicate that future education should focus on improving communication with doctors.

References

Stovner LJ, Hagen K, Linde M, Steiner TJ. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain. 2022;23(1):1-7.

O'Neal KS, Murray KA, Skomo ML, Carter SM, McConaha J. Validation of a survey tool assessing effectiveness of an educational intervention on the caring behaviors and referral activities of community pharmacists for migraineurs. Res Social Adm Pharm. 2015;11(3):352-63.

Published
2022/10/18
Section
Poster presentations session Pharmaceutical Care